Findings underscore importance of nutrition for both healthy pregnancy, early childhood development; OHSU expanding prenatal nutrition counseling, access to healthy foods.
In expanding our knowledge of how the brain controls the process of sexual development, researchers at Oregon Healthy & Science University and the University of Pittsburgh have identified for the first time members of an elaborate superfamily of genes that regulate the timing of puberty in highly evolved nonhuman primates. The Zinc finger, or ZNF, gene family comprises approximately 800 individual genes.
Cancer Research UK, one of the largest funders of cancer research globally, and the Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, have formed an international collaboration to accelerate research in the early detection of cancer.
A coordinated push to decrypt a complex form of leukemia is delivering a trove of new drug candidates and treatment ideas, a dozen of which will be presented at the American Society of Hematology Annual Meeting in Orlando, Florida (Dec. 5-8).
Reports of “super responders” – patients who do exceptionally well on a cancer treatment –may be driving unfounded assumptions about the effectiveness of the drugs involved, researchers caution.
A massive search involving cancer researchers across the U.S. and Canada has revealed many of the altered genes and cell signaling pathways that drive a poorly understood form of kidney cancer, primary papillary renal cell carcinoma.
Bay Area Hospital and the OHSU Knight Cancer Institute have agreed to launch the first site of the newly formed OHSU Knight Cancer Network at the Bay Area Cancer Center in Coos Bay, Oregon.
Oregon Health & Science University is one of 40 centers across the country participating in an emergency medicine study that aims to save and improve the lives of adults and children 2 years and older whose life-threatening seizures are resistant to standard treatment.
Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient’s immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.
In a slight knock on digital and telephone communications, a new study points to the unsurpassed mental health benefits of regular face-to-face social interactions among older adults.